Abstract
Mark Gv, Tittel SR, Sziegoleit S, et al. Type 2 diabetes in older patients: an analysis of the DPV and DIVE databases, Ther Adv Endocrinol Metab, 2020; 11: 1–14. DOI: 10.1177/2042018820958296.
In the above referenced article, the correct version of figure 2 is:
Treatment strategy versus clinical variables.(a) Treatment strategy by age groups; (b) HbA1c and treatment strategy by age groups; (c) BMI and treatment strategy by age groups; (d) CKD and treatment strategy by age groups; (e) Proportion of patients with at least one severe hypoglycemia event during the most actual documented treatment year by treatment strategy and age groups; (f) Proportion of patients with at least one diabetic ketoacidosis event during the most actual documented treatment year by treatment strategy and age groups. Oral, oral antidiabetic treatment or treatment with Glucagon-like Peptide 1. BMI, body mass index; CKD, chronic kidney disease; HbA1c, hemoglobin A1c.